4//SEC Filing
van Dijk Marcus Antonius 4
Accession 0000899243-22-003171
CIK 0001840229other
Filed
Jan 24, 7:00 PM ET
Accepted
Jan 25, 5:19 PM ET
Size
5.6 KB
Accession
0000899243-22-003171
Insider Transaction Report
Form 4
van Dijk Marcus Antonius
Chief Technology Officer
Transactions
- Award
Stock Option (Right to Buy)
2022-01-21+62,500→ 62,500 totalExercise: $3.12Exp: 2032-01-21→ Common Stock (62,500 underlying)
Footnotes (1)
- [F1]Represents an option to purchase shares of the common stock, which vests as to 35% of the underlying shares on January 21, 2025 and as to the remaining 65% of the underlying shares on January 21, 2026; provided that the Reporting Person maintains a business relationship with the Issuer through each such vesting date.
Documents
Issuer
MiNK Therapeutics, Inc.
CIK 0001840229
Entity typeother
Related Parties
1- filerCIK 0001881659
Filing Metadata
- Form type
- 4
- Filed
- Jan 24, 7:00 PM ET
- Accepted
- Jan 25, 5:19 PM ET
- Size
- 5.6 KB